--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Medela EU Symposium 2025" developer_entity: "AIM PORTUGAL - VIAGENS, CONGRESSOS E INCENTIVOS, LDA" bundle_id: "com.aim.events.medelaeu2025" app_store_id: "6754881981" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2025-11-05" report_date: "2026-08-08" last_verified: "2026-08-08T00:00:00.000Z" report_version: "1.0" total_reviews: 0 confidence: "low" confidence_score: 0.05 data_age_days: 28 momentum_velocity: "zombie" intelligence_version: 3 tags: ["medical", "free", "mobile app", "app review", "app analysis", "medical", "professionals", "industry"] canonical_url: "https://marlvel.ai/apps/medela-eu-symposium-2025" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Medela EU Symposium 2025 Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free > **TL;DR:** Medela EU Symposium 2025 is a medical app by AIM PORTUGAL - VIAGENS, CONGRESSOS E INCENTIVOS, LDA, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Medela EU Symposium 2025 is a medical app by AIM PORTUGAL - VIAGENS, CONGRESSOS E INCENTIVOS, LDA. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | AIM PORTUGAL - VIAGENS, CONGRESSOS E INCENTIVOS, LDA | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0.05/1.0) | | **Data Age** | 28d | ## Metadata & Market Performance - **Publisher:** AIM PORTUGAL - VIAGENS, CONGRESSOS E INCENTIVOS, LDA - **Category:** Medical - **Target Audience:** Medical professionals and industry stakeholders attending the Medela EU Symposium 2025. - **Platforms:** iOS - **Version Reviewed:** 1.0 - **Report Date:** 2026-08-08 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 6754881981 - **Bundle ID:** com.aim.events.medelaeu2025 - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-08 ## Executive Snapshot **What it is:** Medela EU Symposium 2025 is a mobile event utility for medical professionals, providing schedules, networking, and notifications on iOS. **Why users hire it:** Attendees hire this app to navigate symposium logistics and connect with peers, replacing physical event materials with a digital, updateable schedule. ## App DNA (Features & Intent) - **[Standard] Event Schedule Access:** Centralized view of symposium sessions and speaker information. - **[Standard] Participant Interaction:** In-app communication tools for networking with other event attendees. * *User Intent:* Users want real-time communication within the app experience. - **[Standard] Push Notifications:** Direct alerts from organizers regarding schedule changes or event updates. * *User Intent:* Users want timely prompts to stay engaged without missing updates. - **[Standard] Feedback Collection:** In-app forms for participants to submit evaluations of the event. ## Market Position {#market-position} The app operates as a niche medical event utility with no active chart presence. The lack of updates over 9 months signals a maintenance-mode posture typical of single-event software. ## Monetization Strategy - **Model:** Free - **Tiers:** Free to download and use for symposium attendees - **Analysis:** The app functions as a complimentary utility for event participants, with no direct consumer monetization. ## SWOT Analysis {#swot} **Core Strengths:** - Centralized event-day utility replaces physical brochures - Push notification channel enables real-time schedule updates **Growth Levers:** - Integrating medical resource libraries could extend app utility ## Recent Changes (v2 → v3) {#recent-changes} The analysis shifted from a focus on simple event-day utility to a strategic recommendation for replacing the native app with a web-based portal. **Overall trend**: Stable **Compared at**: 2026-08-08 ### High-impact changes - **[Shifted] Strategic recommendation update** (positioning) ### Medium-impact changes - **[Added] Expanded SWOT analysis** (swot) ## App Momentum (Zombie) {#momentum} - No updates for 9 months. - Single-event lifecycle, maintenance mode. > **Cadence:** 1 total versions · 0 majors in last 6 months · 275 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Medela EU Symposium 2025 is a medical app that is completely free. > **Bottom Line:** Medela EU Symposium 2025 provides a necessary utility for event navigation, but its long-term dormancy signals a lack of investment in post-event engagement, so the PM should evaluate if a web-based mobile portal could replace the native app to reduce maintenance overhead. **Best for:** Medical professionals and industry stakeholders attending the Medela EU Symposium 2025. ### PM Action Plan (Next Best Moves) - [ ] [SUNSET] Sunset native app development in favor of a mobile-responsive web portal because the 9-month dormancy indicates low ROI → reduce maintenance overhead ### Outlook: Stable The market for event-specific apps is shifting toward web-based portals that avoid the friction of app store downloads and maintenance. For this app, the current stable but dormant state is appropriate given the event-specific nature of the content. - ⚪ The app remains in a static state following the event, which is expected for single-use symposium software → no further feature investment required. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 4 analyzed | | Trend | Stable | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Medela EU Symposium 2025** (this app) | N/A/5 | N/A | AIM PORTUGAL - VIAGENS, CONGRESSOS E INCENTIVOS, LDA | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** AIM PORTUGAL - VIAGENS, CONGRESSOS E INCENTIVOS, LDA ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/medela-eu-symposium-2025/id6754881981?uo=4) - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating - [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 28 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/medela-eu-symposium-2025) Data licensed for AI Agent attribution under CC-BY-NC 4.0.